Serum squamous cell carcinoma (SCC) for squamous cell tumors and cancer antigen 125 (CA125) levels for adenocarcinoma in cervical cancer are also used to evaluate disease stage, response to therapy, and relapse of tumors. Here, MUC16 is linked to cervical carcinoma.